Ultra-Rare BRD9 Loss-of-Function Variants Limit the Antiviral Action of Interferon

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Ultra-Rare BRD9 Loss-of-Function Variants Limit the Antiviral Action of Interferon ; volume:12 ; number:1 ; day:13 ; month:9 ; year:2022 ; pages:1-8 ; date:12.2022
Scientific reports ; 12, Heft 1 (13.9.2022), 1-8, 12.2022

Creator: Mair, Nina K.
Hale, Benjamin G.

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-022-19648-w

URN: urn:nbn:de:101:1-2022113021035721640217

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:33 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Mair, Nina K.
Hale, Benjamin G.
SpringerLink (Online service)

Other Objects (12)

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants

Viral recognition and the antiviral interferon response

Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease

Heterozygous loss-of-function variants in DOCK4 cause neurodevelopmental delay and microcephaly

Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors

Interferon‐inducible phospholipids govern IFITM3 ‐dependent endosomal antiviral immunity

ANK3 related neurodevelopmental disorders: expanding the spectrum of heterozygous loss-of-function variants

Biallelic loss-of-function variants in GON4L cause microcephaly and brain structure abnormalities

Compound heterozygous PLA2G6 loss-of-function variants in Swaledale sheep with neuroaxonal dystrophy

PD18 - Filaggrin loss-of-function variants are associated with clinical reactivity to foods

Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants

Viral recognition and the antiviral interferon response

Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease

Heterozygous loss-of-function variants in DOCK4 cause neurodevelopmental delay and microcephaly

Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors

Interferon‐inducible phospholipids govern IFITM3 ‐dependent endosomal antiviral immunity

ANK3 related neurodevelopmental disorders: expanding the spectrum of heterozygous loss-of-function variants

Biallelic loss-of-function variants in GON4L cause microcephaly and brain structure abnormalities

Compound heterozygous PLA2G6 loss-of-function variants in Swaledale sheep with neuroaxonal dystrophy

PD18 - Filaggrin loss-of-function variants are associated with clinical reactivity to foods

Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants

Viral recognition and the antiviral interferon response

Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease

Heterozygous loss-of-function variants in DOCK4 cause neurodevelopmental delay and microcephaly

Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors

Interferon‐inducible phospholipids govern IFITM3 ‐dependent endosomal antiviral immunity

ANK3 related neurodevelopmental disorders: expanding the spectrum of heterozygous loss-of-function variants

Biallelic loss-of-function variants in GON4L cause microcephaly and brain structure abnormalities

Compound heterozygous PLA2G6 loss-of-function variants in Swaledale sheep with neuroaxonal dystrophy

PD18 - Filaggrin loss-of-function variants are associated with clinical reactivity to foods

Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Ultra-Rare BRD9 Loss-of-Function Variants Limit the Antiviral Action of Interferon

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants

Viral recognition and the antiviral interferon response

Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease

Heterozygous loss-of-function variants in DOCK4 cause neurodevelopmental delay and microcephaly

Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors

Interferon‐inducible phospholipids govern IFITM3 ‐dependent endosomal antiviral immunity

ANK3 related neurodevelopmental disorders: expanding the spectrum of heterozygous loss-of-function variants

Biallelic loss-of-function variants in GON4L cause microcephaly and brain structure abnormalities

Compound heterozygous PLA2G6 loss-of-function variants in Swaledale sheep with neuroaxonal dystrophy

PD18 - Filaggrin loss-of-function variants are associated with clinical reactivity to foods

Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants

Viral recognition and the antiviral interferon response

Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease

Heterozygous loss-of-function variants in DOCK4 cause neurodevelopmental delay and microcephaly

Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors

Interferon‐inducible phospholipids govern IFITM3 ‐dependent endosomal antiviral immunity

ANK3 related neurodevelopmental disorders: expanding the spectrum of heterozygous loss-of-function variants

Biallelic loss-of-function variants in GON4L cause microcephaly and brain structure abnormalities

Compound heterozygous PLA2G6 loss-of-function variants in Swaledale sheep with neuroaxonal dystrophy

PD18 - Filaggrin loss-of-function variants are associated with clinical reactivity to foods

Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants

Viral recognition and the antiviral interferon response

Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease

Heterozygous loss-of-function variants in DOCK4 cause neurodevelopmental delay and microcephaly

Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors

Interferon‐inducible phospholipids govern IFITM3 ‐dependent endosomal antiviral immunity

ANK3 related neurodevelopmental disorders: expanding the spectrum of heterozygous loss-of-function variants

Biallelic loss-of-function variants in GON4L cause microcephaly and brain structure abnormalities

Compound heterozygous PLA2G6 loss-of-function variants in Swaledale sheep with neuroaxonal dystrophy

PD18 - Filaggrin loss-of-function variants are associated with clinical reactivity to foods

Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling

Related objects

Reset password